SCHEMBL22192577

SCHEMBL22192577

c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccccc4c4c3ccc3c5c6oc7ccccc7c6ccc5n(-c5ccccc5)c34)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.35
TSHR P16473 5/20 0.35
LMNA P02545 5/20 0.33
KDM4E B2RXH2 4/20 0.33
HSD17B10 Q99714 3/20 0.33
MAPK1 P28482 1/20 0.33
ALDH1A1 P00352 6/20 0.33
POLB P06746 3/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
BRCA1 P38398 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
USP2 O75604 1/20 0.32
HTT P42858 1/20 0.32
PPARG P37231 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22192385 0.96 MAPT (0.35) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL22192251 0.94 MAPT (0.35) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL22192325 0.94 MAPT (0.35) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL22192493 0.93 ALDH1A1 (0.35) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL22192472 0.93 MAPT (0.34) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL22192533 0.93 MAPT (0.35) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL22192424 0.92 MAPT (0.35) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL22192761 0.92 MAPT (0.35) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL22192324 0.92 MAPT (0.35) MAPTTSHRLMNAKDM4EHSD17B10
SCHEMBL22192331 0.92 MAPT (0.35) MAPTTSHRLMNAKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10703762-B2 Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus IDEMITSU KOSAN CO., LTD. (JP) 2020-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10703762-B2 Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus PIEZO1, OR10J3, EPCAM MAPT 1462/4885TSHR 4280/4885LMNA 2806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.